ロード中...
A Druggable Genome Screen Identifies Modifiers of α-Synuclein Levels via a Tiered Cross-Species Validation Approach
Accumulation of α-Synuclein (α-Syn) causes Parkinson's disease (PD) as well as other synucleopathies. α-Syn is the major component of Lewy bodies and Lewy neurites, the proteinaceous aggregates that are a hallmark of sporadic PD. In familial forms of PD, mutations or copy number variations in S...
保存先:
| 出版年: | J Neurosci |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society for Neuroscience
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199406/ https://ncbi.nlm.nih.gov/pubmed/30249792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.0254-18.2018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|